One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The selected official and mirror tables agree. Their CRRT guidance is explicitly initial and depends on effluent rather than a CrCl band.
What to reconcile: Confirm modality and L/hour effluent, then reassess residual function and clinical status; do not interpolate a new algorithm.
Open this note and its source referencesThe official label uses CrCl >=120; UCSF prints >120 beside 60-119. The upper effluent band is >=4.1 L/hour in the label versus >4 in UCSF.
What to reconcile: For exactly CrCl 120 the official label is explicit. Preserve the institutional discrepancy and seek clarification for effluent values between printed bands; do not interpolate. This is a wording/boundary comparison, not evidence of different clinical outcomes.
Open this note and its source referencesDialysis evidence: CRRT effluent-based initial regimen
Using Cockcroft-Gault CrCl (mL/min), the adult regimen is 2 g every 8 hours at 60-119; 1.5 g every 8 hours at 30-59; 1 g every 8 hours at 15-29; and 0.75 g every 12 hours below 15 with or without intermittent HD. At >=120 use 2 g every 6 hours. Infuse over 3 hours and administer immediately after intermittent HD.
Initial CRRT doses by effluent L/hour: <=2, 1.5 g every 12 hours; 2.1-3, 2 g every 12 hours; 3.1-4, 1.5 g every 8 hours; >=4.1, 2 g every 8 hours. Tailor for residual renal function and clinical status. These printed intervals are retained, not interpolated into an automated algorithm.
RDM58-official-cefiderocol-4cceb3a62f-C1 · Source locator: Sections 2.1-2.2 Tables 1-2, 8.6; printed date fields
Selected sections only; not a complete prescribing monograph or independent clinician approval.
Exact DailyMed HTML identity and named sections read. Raw SPL XML, original document hash and complete revision history were not obtained. Availability is not established by label retrieval.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=cefiderocol&s1=RDM58-official-cefiderocol-4cceb3a62f&h1=12be5c40d62a500340b04562350c68a02999cb983bc84285745e75bdd23cf79f